J. Molner AS (TAL:MOLNR)

Market Cap	29.51M -27.1%
Revenue	n/a
Net Income	n/a
EPS	n/a
Shares Out	1.69M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1
Open	17.50
Previous Close	17.50
Day's Range	17.50 - 17.50
52-Week Range	10.20 - 30.80
Beta	0.34
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About J. Molner AS

J. Molner AS, a pharmaceutical company, focuses on the development and manufacturing of generic medicines in the United States, Canada, and Europe. The company develops and commercializes sterile injectable, ophthalmic, and dermatology generic drugs. It also offers drug development, analytical chemistry, and stability testing services. The company was founded in 2015 and is based in Tallinn, Estonia.

• Industry: Commercial Physical and Biological Research
• Founded: 2015
• Country: Estonia
• Stock Exchange: Nasdaq Tallinn
• Ticker Symbol: MOLNR

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 18, 2026

Data Sources Report a data error